SCHEMBL20847632

SCHEMBL20847632

O=S(=O)(c1ccc(F)cc1)N(Cc1ccc(F)cc1)C1CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 5/20 0.74
▸ HDAC6 Q9UBN7 5/20 0.74
▸ HDAC3 O15379 2/20 0.74
▸ USP2 O75604 1/20 0.70
▸ ALDH1A1 P00352 1/20 0.70
▸ MEN1 O00255 1/20 0.70
▸ KMT2A Q03164 1/20 0.70
▸ PSEN1 P49768 3/20 0.54
▸ PSEN2 P49810 3/20 0.54
▸ APH1B Q8WW43 3/20 0.54
▸ NCSTN Q92542 3/20 0.54
▸ APH1A Q96BI3 3/20 0.54
▸ PSENEN Q9NZ42 3/20 0.54
▸ CNR1 P21554 4/20 0.53
▸ CNR2 P34972 4/20 0.53
▸ KCNA5 P22460 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ TBXA2R P21731 1/20 0.50
▸ PTGDR Q13258 1/20 0.50
▸ PTGDR2 Q9Y5Y4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839243 0.92 HDAC8 (0.65) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL20393935 0.87 MEN1 (0.69) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL20847550 0.84 HDAC6 (0.68) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL1574683 0.84 CNR1 (0.58) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL14842380 0.83 MEN1 (1.00) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL20387947 0.82 KMT2A (0.67) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL20393932 0.81 KMT2A (0.69) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL20847491 0.81 HDAC6 (0.70) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL20847601 0.80 HDAC6 (0.63) HDAC8HDAC6HDAC3USP2ALDH1A1
SCHEMBL14842844 0.79 MEN1 (0.76) HDAC8HDAC6HDAC3USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200277268-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2020-09-03 — — US disclosed
WO-2019056120-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2019-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277268-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF MKI67, PKD1, ETV6 HDAC8 1916/4885HDAC6 499/4885HDAC3 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback